Sort By
  • Newest

  • Newest

  • Oldest

  • Author Name

  • Author Name

  • Abbey Minogue

  • Drew Meredith

  • Greg Bright

  • Helen Fisher

  • Ishan Dan

  • James Dunn

  • Lachlan Buur-Jensen

  • Lachlan Maddock

  • Staff Writer

  • Tahn Sharpe

  • The Inside Adviser

  • Tim Fuller

How WealthO2 added an ‘X factor’ in board restructure

A small coterie of now well-heeled technology entrepreneurs is responsible for much of the progress seen in that segment of the Australian investment advice landscape for the past 25-or-so years, mostly starting in the days of dial-up modems. Two of them have just joined the board of the latest financial adviser systems firm, the four-year-old…

Greg Bright | 18th Jan 2021 | More
Riding the digital wave

Franklin Templeton and Quantifeed’s plans to lead the digital advice sector Alex Ypsilanti, CEO and co-founder of Quantifeed, and James Verner, vice-president, digital strategy and wealth management at Franklin Templeton, spoke with The Inside Network’s Peter White about the new partnership and their first big project. These days you don’t get very far in terms…

Abbey Minogue | 14th Dec 2020 | More
The power of long-short in a pandemic market

Long-short strategies, which involve giving a fund manager the flexibility to profit when share prices rise or fall, were gaining traction before the pandemic. The trend has continued to accelerate since, but they remain an under-represented part of most investor portfolios. Whether due to a lack of understanding or perceived higher risk, heightened equity market…

The Inside Adviser | 30th Nov 2020 | More
  • Disruptive innovation delivered a 90% return for ARK

    The Dr Cathie Wood-led ARK Investment Management is facing a different kind of pressure as 2020 draws to a close. According to Bloomberg, ARK’s ETF distributor, Resolute Investment Managers, is seeking to exercise an option acquired in 2016 to buy a controlling stake in the business. The ARK Invest strategy has been a clear winner…

    Drew Meredith | 19th Nov 2020 | More
    Pfizer’s Coronavirus vaccine – a closer look

    A major milestone for Pfizer On 9 November 2020, Pfizer announced that its vaccine candidate, developed in collaboration with BioNTech, was more than 90 per cent effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis. After discussion with the US Food and Drug Administration (FDA), Pfizer…

    Helen Fisher | 16th Nov 2020 | More
    Thinking forward: Three ASX biotech stars

    And still they keep coming – here’s the fourth instalment of our series on the fascinating ASX cohort of medical device developers. As always, don’t let the impressive sexiness of the technology persuade you on its own that these stocks are headed for the stars. In each of the three cases presented here, previous investors…

    James Dunn | 5th Nov 2020 | More
  • The time is right for an infrastructure boom, but who will win?

    Long-short strategies, which involve giving a fund manager the flexibility to profit when share prices rise or fall, were gaining traction before the pandemic. The trend has continued to accelerate since, but they remain an underrepresented part of most investor portfolios. Whether due to a lack of understanding or perceived higher risk, heightened equity market…

    The Inside Adviser | 5th Nov 2020 | More
    MDA market review: a watershed year

    Managed Accounts, or Managed Discretionary Accounts (MDAs), are a relatively new investment solution available to consumers and financial advisers following recent advances in platform technology. MDAs have evolved to a point where advisers can offer clients a broad range of investment assets and clients have complete visibility of the investments held in their portfolio. What…

    Ishan Dan | 26th Oct 2020 | More
  • Plans for a simpler, cheaper advice system

    The Financial Services Council (FSC) is to now prepare a policy discussion (a ‘green paper’) for the industry and government, to be delivered in 2021, following the release of a major report by Rice Warner proposing sweeping changes to Australia’s financial advice system. The Rice Warner report was commissioned by the FSC and discussed at…

    Greg Bright | 22nd Oct 2020 | More
    Growth managers continue to shine

    It’s been a while since “value investing” made sense: the style has suffered a dreadful stretch of performance since the 2008 financial crisis. The ‘Warren Buffett’ mantra of buying low (cheap) and selling high has seen value-oriented managers underperform the market year after year. But that’s not to say value investing is dead, it’s just…

    Ishan Dan | 19th Oct 2020 | More